Lam Research Corporation $LRCX Holdings Lowered by Seizert Capital Partners LLC

Seizert Capital Partners LLC lowered its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 33.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 78,716 shares of the semiconductor company’s stock after selling 39,475 shares during the quarter. Seizert Capital Partners LLC’s holdings in Lam Research were worth $10,540,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of LRCX. IMG Wealth Management Inc. acquired a new stake in Lam Research during the 2nd quarter valued at $26,000. Howard Hughes Medical Institute bought a new position in Lam Research in the second quarter worth $27,000. Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the 2nd quarter worth about $29,000. Delos Wealth Advisors LLC bought a new position in shares of Lam Research in the second quarter valued at about $30,000. Finally, REAP Financial Group LLC bought a new position in shares of Lam Research in the 2nd quarter valued at about $31,000. Institutional investors own 84.61% of the company’s stock.

Lam Research Trading Down 1.4%

Shares of LRCX stock opened at $219.94 on Tuesday. The business has a 50-day moving average of $172.73 and a 200 day moving average of $138.40. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $229.57. The stock has a market capitalization of $276.25 billion, a PE ratio of 48.49, a P/E/G ratio of 2.55 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business’s revenue for the quarter was up 27.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, sell-side analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were paid a dividend of $0.26 per share. The ex-dividend date was Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Analysts Set New Price Targets

Several research firms have issued reports on LRCX. Barclays set a $195.00 price target on Lam Research in a research note on Thursday. The Goldman Sachs Group reaffirmed a “buy” rating and set a $180.00 target price on shares of Lam Research in a report on Friday, January 9th. Needham & Company LLC reaffirmed a “buy” rating and set a $250.00 price target (up previously from $160.00) on shares of Lam Research in a report on Tuesday. HSBC lifted their target price on Lam Research from $127.00 to $181.00 and gave the company a “hold” rating in a research report on Friday, January 9th. Finally, B. Riley restated a “buy” rating on shares of Lam Research in a report on Thursday. Twenty-eight analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $192.46.

Insider Buying and Selling

In other Lam Research news, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the sale, the insider owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. The trade was a 13.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Bethany Mayer sold 1,298 shares of the stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the transaction, the director directly owned 1,652 shares in the company, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 50,418 shares of company stock worth $7,667,305 in the last 90 days. 0.31% of the stock is owned by corporate insiders.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.